Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 37

1.

Perioperative SBP changes during orthopedic surgery in the elderly: clinical implications.

Koutsaki M, Thomopoulos C, Achimastos A, Kallistratos M, Batistaki C, Chatziagelaki E, Soulioti E, Poulimenos L, Koutsaki S, Mela A, Mancia G, Manolis AJ.

J Hypertens. 2019 Aug;37(8):1705-1713. doi: 10.1097/HJH.0000000000002085.

PMID:
30950973
2.

Effects of metabolic syndrome on arterial function in different age groups: the Advanced Approach to Arterial Stiffness study.

Topouchian J, Labat C, Gautier S, B├Ąck M, Achimastos A, Blacher J, Cwynar M, de la Sierra A, Pall D, Fantin F, Farkas K, Garcia-Ortiz L, Hakobyan Z, Jankowski P, Jelakovic A, Kobalava Z, Konradi A, Kotovskaya Y, Kotsani M, Lazareva I, Litvin A, Milyagin V, Mintale I, Persson O, Ramos R, Rogoza A, Ryliskyte L, Scuteri A, Sirenko Y, Soulis G, Tasic N, Udovychenko M, Urazalina S, Wohlfahrt P, Zelveian P, Benetos A, Asmar R.

J Hypertens. 2018 Apr;36(4):824-833. doi: 10.1097/HJH.0000000000001631.

3.

The optimal night-time home blood pressure monitoring schedule: agreement with ambulatory blood pressure and association with organ damage.

Kollias A, Andreadis E, Agaliotis G, Kolyvas GN, Achimastos A, Stergiou GS.

J Hypertens. 2018 Feb;36(2):243-249. doi: 10.1097/HJH.0000000000001562.

PMID:
28915229
4.

Thermal ablation may improve outcomes in patients with colorectal liver metastasis: a case-control study.

Poulou LS, Thanos L, Ziakas PD, Merikas E, Achimastos A, Gennatas C, Syrigos KN.

J BUON. 2017 May-Jun;22(3):673-678.

5.

Methodology and technology for peripheral and central blood pressure and blood pressure variability measurement: current status and future directions - Position statement of the European Society of Hypertension Working Group on blood pressure monitoring and cardiovascular variability.

Stergiou GS, Parati G, Vlachopoulos C, Achimastos A, Andreadis E, Asmar R, Avolio A, Benetos A, Bilo G, Boubouchairopoulou N, Boutouyrie P, Castiglioni P, de la Sierra A, Dolan E, Head G, Imai Y, Kario K, Kollias A, Kotsis V, Manios E, McManus R, Mengden T, Mihailidou A, Myers M, Niiranen T, Ochoa JE, Ohkubo T, Omboni S, Padfield P, Palatini P, Papaioannou T, Protogerou A, Redon J, Verdecchia P, Wang J, Zanchetti A, Mancia G, O'Brien E.

J Hypertens. 2016 Sep;34(9):1665-77. doi: 10.1097/HJH.0000000000000969.

PMID:
27214089
6.

Expert consensus on the rational clinical use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors.

Achimastos A, Alexandrides T, Alexopoulos D, Athyros V, Bargiota A, Bilianou E, Chrysochoou C, Drogari E, Elisaf M, Ganotakis E, Goudevenos I, Ioannidis I, Kolovou G, Kotsis V, Lekakis I, Liberopoulos E, Melidonis A, Nikolaou V, Ntaios G, Papanas N, Pappas S, Pitsavos C, Rallidis L, Richter D, Skoumas I, Tentolouris N, Tousoulis D, Tselepis A, Tsioufis K, Tziakas D, Tziomalos K, Vardas P, Vlachopoulos C, Vlahakos D.

Hormones (Athens). 2016 Jan-Mar;15(1):8-14. doi: 10.14310/horm.2002.1659.

7.

Night-time home versus ambulatory blood pressure in determining target organ damage.

Andreadis EA, Agaliotis G, Kollias A, Kolyvas G, Achimastos A, Stergiou GS.

J Hypertens. 2016 Mar;34(3):438-44; discussion 444. doi: 10.1097/HJH.0000000000000815.

PMID:
26727487
8.

The diverse roles of adiponectin in non-small-cell lung cancer: current data and future perspectives.

Boura P, Loukides S, Grapsa D, Achimastos A, Syrigos K.

Future Oncol. 2015;11(15):2193-203. doi: 10.2217/fon.15.96. Review.

PMID:
26235182
9.

Renal denervation in treating resistant hypertension: does it have a future?

Stergiou GS, Achimastos A.

Hellenic J Cardiol. 2014 Nov-Dec;55(6):439-41. No abstract available.

10.

Cost estimation of hypertension management based on home blood pressure monitoring alone or combined office and ambulatory blood pressure measurements.

Boubouchairopoulou N, Karpettas N, Athanasakis K, Kollias A, Protogerou AD, Achimastos A, Stergiou GS.

J Am Soc Hypertens. 2014 Oct;8(10):732-8. doi: 10.1016/j.jash.2014.07.027. Epub 2014 Jul 16.

PMID:
25418495
11.

Left-ventricular hypertrophy is associated better with 24-h aortic pressure than 24-h brachial pressure in hypertensive patients: the SAFAR study.

Protogerou AD, Argyris AA, Papaioannou TG, Kollias GE, Konstantonis GD, Nasothimiou E, Achimastos A, Blacher J, Safar ME, Sfikakis PP.

J Hypertens. 2014 Sep;32(9):1805-14. doi: 10.1097/HJH.0000000000000263.

PMID:
24999798
12.

Stress management and dietary counseling in hypertensive patients: a pilot study of additional effect.

Katsarou AL, Vryonis MM, Protogerou AD, Alexopoulos EC, Achimastos A, Papadogiannis D, Chrousos GP, Darviri C.

Prim Health Care Res Dev. 2014 Jan;15(1):38-45. doi: 10.1017/S1463423612000679. Epub 2013 Feb 21.

PMID:
23425517
13.

Long-term impact of multifactorial treatment on new-onset diabetes and related cardiovascular events in metabolic syndrome: a post hoc ATTEMPT analysis.

Athyros VG, Elisaf MS, Alexandrides T, Achimastos A, Ganotakis E, Bilianou E, Karagiannis A, Liberopoulos EN, Tziomalos K, Mikhailidis DP; Assessing the Treatment Effect in Metabolic Syndrome Without Perceptible Diabetes (ATTEMPT) Collaborative Group.

Angiology. 2012 Jul;63(5):358-66. doi: 10.1177/0003319711421341. Epub 2011 Oct 17.

PMID:
22007026
14.

Assessing the treatment effect in metabolic syndrome without perceptible diabetes (ATTEMPT): a prospective-randomized study in middle aged men and women.

Athyros VG, Ganotakis E, Kolovou GD, Nicolaou V, Achimastos A, Bilianou E, Alexandrides T, Karagiannis A, Paletas K, Liberopoulos EN, Tziomalos K, Petridis D, Kakafika A, Elisaf MS, Mikhailidis DP; Assessing The Treatment Effect in Metabolic Syndrome Without Perceptible Diabetes (ATTEMPT) Collaborative.

Curr Vasc Pharmacol. 2011 Nov;9(6):647-57.

PMID:
21476961
15.

Multiplexed analysis of angiogenesis and lymphangiogenesis factors predicts outcome for non-small cell lung cancer patients.

Anagnostou VK, Tiniakos DG, Fotinou M, Achimastos A, Syrigos KN.

Virchows Arch. 2011 Mar;458(3):331-40. doi: 10.1007/s00428-010-1015-4. Epub 2010 Dec 14.

PMID:
21161269
16.

Blood pressure levels constitute the most important determinant of the metabolic syndrome in a Mediterranean population: a discrimination analysis.

Chimonas T, Karagiannis A, Athyros VG, Achimastos A, Elisaf M, Panagiotakos DB; Assessing The Treatment Effect in Metabolic Syndrome Without Perceptible diabeTes (ATTEMPT) Collaborative Group.

Metab Syndr Relat Disord. 2010 Dec;8(6):523-9. doi: 10.1089/met.2010.0023. Epub 2010 Aug 17.

PMID:
20715970
17.

Nitric oxide, ammonia, and CRP levels in cirrhotic patients with hepatic encephalopathy: is there a connection?

Papadopoulos N, Soultati A, Goritsas C, Lazaropoulou C, Achimastos A, Adamopoulos A, Dourakis SP.

J Clin Gastroenterol. 2010 Nov-Dec;44(10):713-9. doi: 10.1097/MCG.0b013e3181d47f71.

PMID:
20495469
18.

Fever of unknown origin: discrimination between infectious and non-infectious causes.

Efstathiou SP, Pefanis AV, Tsiakou AG, Skeva II, Tsioulos DI, Achimastos AD, Mountokalakis TD.

Eur J Intern Med. 2010 Apr;21(2):137-43. doi: 10.1016/j.ejim.2009.11.006. Epub 2009 Dec 6.

PMID:
20206887
19.

Polymorphisms of fractalkine receptor CX3CR1 gene in patients with symptomatic and asymptomatic carotid artery stenosis.

Kimouli M, Miyakis S, Georgakopoulos P, Neofytou E, Achimastos AD, Spandidos DA.

J Atheroscler Thromb. 2009 Oct;16(5):604-10. Epub 2009 Sep 16.

20.

A patient with recurrent episodes of abdominal pain and hypovolemic shock.

Solomon S, Pefanis A, Papaetis GS, Ginos C, Kythreotis P, Achimastos A.

Am J Emerg Med. 2009 Jul;27(6):755.e5-7. doi: 10.1016/j.ajem.2008.10.010. No abstract available.

PMID:
19751646

Supplemental Content

Loading ...
Support Center